THEOPHYLLINE
Active substance: theophylline
TABLET, EXTENDED RELEASE · THEOPHYLLINE 450 mg/1
United StatesActive
Marketing holder: Leading Pharma, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- THEOPHYLLINE · 450 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 13 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4f1e-7d3b-ae14-e0d35e91fb1d,01a1208c-7265-7225-92a7-92729cb20ded,01a1208c-88c7-72c5-a4ca-1e5b6bcf1211,01a1208c-a6de-726e-a4d6-d3a3a2dca0fb,01a1208d-3b5f-7895-a050-802591c9fa26;count=51 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69315-227
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 69315-227 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69315-227 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69315-227 · Verified 2026-10-09 · open in source